ArticleHuman vaccines & immunotherapeutics2021

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.

Abdolkarim Sheikhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.